New OTC drugs and devices 1997: a selective review.
OBJECTIVE
To create a heightened awareness of the proposals for nonprescription product labeling changes being explored by the Food and Drug Administration and the Nonprescription Drug Manufacturers Association, and to review selected new self-care products that are now available in the United States.


METHODS
Recent clinical and pharmaceutical industry literature.


RESULTS
The debate continues about what constitutes sufficient labeling information for a nonprescription drug product. However, one fact remains. Numerous nonprescription drug products, including home diagnostic products and accessories, will continue to become available on the U.S. market. It is important that the pharmacist become as knowledgeable as possible about these products, and be capable of educating consumers on their appropriate use.


CONCLUSIONS
New products cited in this review article are valuable new additions to the self-care product pool that provides an increasing array of products for consumer use.
Newton
G D
GD
Mylan School of Pharmacy, Duquesne University, Pittsburgh, Pa., USA.
Pray
W S
WS
Popovich
N G
NG
D001249:Asthma / Q000188:drug therapy; D003261:Contact Lenses; D003967:Diarrhea / Q000188:drug therapy; D007172:Erectile Dysfunction / Q000628:therapy; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D004366:Nonprescription Drugs / Q000627:therapeutic use*; D012648:Self Care
D004366:Nonprescription Drugs